These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26806677)

  • 21. Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012.
    Duclos P; Dumolard L; Abeysinghe N; Adjagba A; Janusz CB; Mihigo R; Mosina L; Takashima Y; Oztürk MH
    Vaccine; 2013 Nov; 31(46):5314-20. PubMed ID: 24055304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries.
    van Zandvoort K; Howard N; Mounier-Jack S; Jit M
    Vaccine; 2019 Jan; 37(3):430-434. PubMed ID: 30545715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examining the views of key stakeholders regarding the provision of occupational influenza vaccination for healthcare workers in Australia.
    Lim YC; Seale H
    Vaccine; 2014 Jan; 32(5):606-10. PubMed ID: 24291538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of IV behaviors during and after the 2009 influenza pandemic in France.
    Anne-Laure CB; Jocelyn R; Nathanaël L; Xavier De-Lambal ; Fabrice C; Michel S
    Vaccine; 2014 Apr; 32(17):2007-15. PubMed ID: 24434043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moving forward on strengthening and sustaining National Immunization Technical Advisory Groups (NITAGs) globally: Recommendations from the 2nd global NITAG network meeting.
    MacDonald NE; Duclos P; Wichmann O; Henaff L; Harnden A; Alshammary A; Tijerino RA; Hall M; Sacarlal J; Singh RR
    Vaccine; 2017 Dec; 35(50):6925-6930. PubMed ID: 29103592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings.
    Ortiz JR; Neuzil KM; Ahonkhai VI; Gellin BG; Salisbury DM; Read JS; Adegbola RA; Abramson JS
    Vaccine; 2012 Nov; 30(50):7134-40. PubMed ID: 23026690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Narrowing the policy gap: lessons from years 2 and 3 of the British Columbia influenza prevention policy.
    Di Castri AM; Halperin DM; McPherson CM; Nunn A; Farrar-Muir H; Kwong JC; Henry B
    Hum Vaccin Immunother; 2020 Jun; 16(6):1354-1363. PubMed ID: 31922460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns.
    Flicoteaux R; Pulcini C; Carrieri P; Schwarzinger M; Leport C; Verger P
    Vaccine; 2014 Apr; 32(20):2281-7. PubMed ID: 24631097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The French Committee for the prevention and control of influenza and the 2009 influenza pandemic: Lessons learnt].
    Manuguerra JC; Mosnier A; Autran B; Fleury M; Veyssier P; Patey O; Weil-Olivier C; Beytout J; Bensoussan JL; Nicand E
    Presse Med; 2012 Sep; 41(9 Pt 1):783-92. PubMed ID: 22560684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Questions for future evidence-informed policy initiatives: insights from the evolution and aspirations of National Immunization Technical Advisory Groups.
    Buffardi AL; Njambi-Szlapka S
    Health Res Policy Syst; 2020 Apr; 18(1):40. PubMed ID: 32321521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Making influenza vaccination mandatory for health care workers: the views of NSW Health administrators and clinical leaders.
    Leask J; Helms CM; Chow MY; Robbins SC; McIntyre PB
    N S W Public Health Bull; 2010; 21(9-10):243-7. PubMed ID: 21211478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future pandemics and vaccination: Public opinion and attitudes across three European countries.
    Determann D; de Bekker-Grob EW; French J; Voeten HA; Richardus JH; Das E; Korfage IJ
    Vaccine; 2016 Feb; 34(6):803-8. PubMed ID: 26740251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Journey to vaccination: a protocol for a multinational qualitative study.
    Wheelock A; Miraldo M; Parand A; Vincent C; Sevdalis N
    BMJ Open; 2014 Jan; 4(1):e004279. PubMed ID: 24486678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities.
    Steffen CA; Henaff L; Durupt A; Omeiri NE; Ndiaye S; Batmunkh N; Liyanage JBL; Hasan Q; Mosina L; Jones I; O'Brien K; Hombach J
    Vaccine; 2021 Apr; 39(15):2146-2152. PubMed ID: 33712350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccination in kids, are you kidding me?
    Ahout I; Ferwerda G; de Groot R
    J Infect; 2014 Jan; 68 Suppl 1():S100-7. PubMed ID: 24206897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly.
    Blank P; Schwenkglenks M; Szucs TD
    Hum Vaccin Immunother; 2012 Mar; 8(3):328-35. PubMed ID: 22327498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the role of disease severity in drug reimbursement decision making in four European countries.
    Franken M; Stolk E; Scharringhausen T; de Boer A; Koopmanschap M
    Health Policy; 2015 Feb; 119(2):195-202. PubMed ID: 25456017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The French Technical Vaccination Committee (CTV).
    Floret D; Deutsch P
    Vaccine; 2010 Apr; 28 Suppl 1():A42-7. PubMed ID: 20412996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Power and Agenda-Setting in Tanzanian Health Policy: An Analysis of Stakeholder Perspectives.
    Fischer SE; Strandberg-Larsen M
    Int J Health Policy Manag; 2016 Feb; 5(6):355-63. PubMed ID: 27285513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.